An Infant Formula Trial on Dietary Management of Infantile Colic
A Randomised, Double Blind, Controlled, Multi-centre Study to Assess the Efficacy of an Infant Formula in the Dietary Management of Infantile Colic
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
A randomised, double blind, controlled, multi-centre study to assess the efficacy of an infant formula in the dietary management of infantile colic.
The hypothesis of the study is that the test product, compared to the control formula, will reduce the crying time in infants with infantile colic.
The various time points of the outcome are:
V1 (screening : Day -5 to day 0); V2 ( Randomization: Day 0); V3 (Day 7); V4 (Day 21); Phone Call (Day 28); V5 (End -intervention: Day 42); V6 (Day 56)
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Infants aged 21-56 days (both inclusive);
- Gestation age 37-42 weeks;
- Normal birth weight for gestational age and gender
- 5-minute APGAR score >7;
- Diagnosed with infantile colic ;
- Fully formula fed for at least 7 days before randomisation;
- Written informed consent from the parent and/or legal representative.
Exclusion Criteria:
- Any plausible cause of inconsolable crying as judged by the investigator;
- Presence of non-functional vomiting or failure to thrive;
- Presence of any congenital defects in the gastrointestinal system or other defects preventing oral nutrition;
- Congenital condition and/or previous or current illness/infection and (or) medication use that could interfere with the main study outcomes;
- Known cow's milk protein allergy, lactose intolerance, or galactosaemia; including presence of any allergic manifestations;
- Received any special formula (e.g. lactose-free, hydrolysed protein);
Received any of the following products/medication within 7 days before randomisation:
- Probiotics
- Systemic antibiotics
- Prokinetics
- Proton pump inhibitors
- Twins or triplets or other infant(s) <6 months of age living in the same household;
- Incapability of the parent(s) to comply with the study protocol or investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements;
- Current participation in another clinical study involving investigational or marketed products.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Intervention group
An infant formula which contains specific hydrolysed proteins with a fat blend, prebiotics mixture, starch and reduced lactose
|
An infant formula which contains specific hydrolysed proteins with a fat blend, prebiotics mixture, starch and reduced lactose
|
|
Aktiv komparator: Control group
Standard cow's milk with prebiotics mixture
|
Standard cow's milk with prebiotics mixture
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Daily inconsolable crying time using data recorded on subject's diaries
Tidsramme: 6 weeks
|
Daily inconsolable crying time over 6 weeks
|
6 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Daily crying time using data recorded on subject's diaries
Tidsramme: 6 weeks
|
Daily crying time over 6 weeks of intervention
|
6 weeks
|
|
Daily fussing time using data recorded on subject's diaries
Tidsramme: 6 weeks
|
Daily fussing time over 6 weeks of intervention
|
6 weeks
|
|
Daily inconsolable fussing time using data recorded on subject's diaries
Tidsramme: 6 weeks
|
Daily inconsolable fussing time over 6 weeks of intervention
|
6 weeks
|
|
Daily stool frequency using data recorded on subject's diaries
Tidsramme: 6 weeks
|
Daily stool frequency over 6 weeks of intervention
|
6 weeks
|
|
Daily stool consistency using data recorded on subject's diaries
Tidsramme: 6 weeks
|
Daily stool consistency over 6 weeks of intervention
|
6 weeks
|
|
The frequency of subject's GI symptoms of digestion in the 7-day period prior to the visit using the Infant gastrointestinal symptoms questionnaire
Tidsramme: 6 weeks
|
Gastrointestinal symptoms using the Infant gastrointestinal symptoms questionnaire during the 6-week intervention period
|
6 weeks
|
|
The intensity of subject's GI symptoms of digestion in the 7-day period prior to the visit using the Infant gastrointestinal symptoms questionnaire
Tidsramme: 6 weeks
|
Gastrointestinal symptoms using the Infant gastrointestinal symptoms questionnaire during the 6-week intervention period
|
6 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- EBB16SI06749
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .